Aspersteroids A and B are novel ergostane-type
18,22-cyclosterols
with immunosuppressive and antimicrobial activities. Herein, we report
the first synthesis of these two natural products, which was accomplished
in 15 and 14 steps, respectively, from commercially available ergosterol
by means of a bioinspired divergent approach. Key features of this
synthesis include an unprecedented radical relay cyclization that
was initiated by iron(II)-mediated decomposition of an alkyl hydroperoxide
to construct the E ring cyclopentane motif; a titanium(III)-mediated
diastereoselective radical reduction of an epoxide to install the
challenging C22 stereocenter; and highly regioselective, divergent
late-stage oxidations to access the highly oxidized core framework.